ADMA Biologics, Inc. (ADMA)
10.68
-0.27
(-2.47%)
USD |
NASDAQ |
Oct 23, 16:00
10.68
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Price : 10.68 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 10.88 | 10.90 | 10.57 | 10.68 | 1.741M |
| Oct 22, 2026 | 11.01 | 11.10 | 10.80 | 10.95 | 3.552M |
| Oct 21, 2026 | 11.17 | 11.28 | 10.92 | 11.01 | 2.006M |
| Oct 20, 2026 | 11.12 | 11.32 | 11.03 | 11.23 | 2.897M |
| Oct 19, 2026 | 10.66 | 11.14 | 10.66 | 11.07 | 2.874M |
| Oct 16, 2026 | 10.73 | 10.87 | 10.60 | 10.68 | 3.074M |
| Oct 15, 2026 | 10.60 | 10.91 | 10.48 | 10.73 | 2.772M |
| Oct 14, 2026 | 10.31 | 10.60 | 10.24 | 10.34 | 2.876M |
| Oct 13, 2026 | 10.19 | 10.36 | 10.02 | 10.31 | 3.765M |
| Oct 12, 2026 | 10.32 | 10.40 | 10.16 | 10.18 | 1.627M |
| Oct 09, 2026 | 10.32 | 10.50 | 10.25 | 10.36 | 2.828M |
| Oct 08, 2026 | 10.09 | 10.44 | 10.03 | 10.33 | 3.903M |
| Oct 07, 2026 | 10.15 | 10.32 | 10.07 | 10.14 | 3.050M |
| Oct 06, 2026 | 10.20 | 10.35 | 9.98 | 10.18 | 2.100M |
| Oct 05, 2026 | 9.63 | 10.19 | 9.62 | 10.11 | 3.512M |
| Oct 02, 2026 | 10.02 | 10.28 | 9.68 | 9.72 | 2.793M |
| Oct 01, 2026 | 10.07 | 10.26 | 9.905 | 9.93 | 3.970M |
| Sep 30, 2026 | 9.98 | 10.14 | 9.795 | 10.03 | 2.699M |
| Sep 29, 2026 | 10.04 | 10.18 | 9.894 | 9.96 | 3.458M |
| Sep 28, 2026 | 9.38 | 10.17 | 9.25 | 10.12 | 3.568M |
| Sep 25, 2026 | 9.55 | 9.625 | 9.23 | 9.38 | 3.567M |
| Sep 24, 2026 | 9.67 | 9.825 | 9.37 | 9.52 | 2.587M |
| Sep 23, 2026 | 9.81 | 9.84 | 9.43 | 9.70 | 2.595M |
| Sep 22, 2026 | 9.535 | 9.835 | 9.45 | 9.81 | 2.738M |
| Sep 21, 2026 | 9.185 | 9.54 | 9.10 | 9.505 | 2.859M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vericel Corp. | 42.53 |
| BioMarin Pharmaceutical, Inc. | 55.95 |
| Emergent BioSolutions, Inc. | 6.23 |
| Exelixis, Inc. | 64.53 |
| Akebia Therapeutics, Inc. | 0.5669 |
Price Related Metrics
| PE Ratio | 15.16 |
| PS Ratio | 4.997 |
| Price to Book Value | 5.896 |
| Price to Free Cash Flow | 22.03 |
| Earnings Yield | 6.60% |
| Market Cap | 2.407B |
| Operating PE Ratio | 11.82 |
| Normalized PE Ratio | 15.03 |